Research Articles | Page 21 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Revisiting use of growth factors in myelodysplastic syndromes May 2012 Asian Pac J Cancer Prev myelodysplastic syndromes (MDS)
Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes Jun 2012 Blood myelodysplastic syndromes (MDS)
Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Jun 2013 J Clin Oncol myelodysplastic syndromes (MDS)
Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant. Jan 2019 Crit Rev Oncol Hematol myelodysplastic syndromes (MDS)
Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation. Aug 2013 Bone Marrow Transplant aplastic anemia
Retrospective Analysis of Prognostic Factors Associated With Response and Overall Survival by Baseline Marrow Blast Percentage in Patients With Myelodysplastic Syndromes Treated With Decitabine. Jun 2013 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Rethinking clinical trial endpoints in myelodysplastic syndromes. Jan 2019 Leukemia myelodysplastic syndromes (MDS)
Response to pre-transplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes Nov 2012 Eur J Haematol myelodysplastic syndromes (MDS)
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations. Apr 2013 Br J Haematol myelodysplastic syndromes (MDS)
Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia. Jun 2014 Haematologica myelodysplastic syndromes (MDS)
Share with addtoany.com.